Companies: 10,795·Total market cap: $144.5T
Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.

CRLNYSEHealthcare● Active
$186.44
+$5.10(+2.81%)
Market Cap$9.0B
P/E Ratio
52W High$228.88
52W Low$140.78

Charles River Laboratories International, Inc. (CRL) Revenue

Annual & quarterly revenue history · segment & region breakdown

CRL · revenue · updated Jun 8, 2026

Core revenue metrics

Charles River Laboratories International, Inc. trailing twelve-month (TTM) revenue is $4.03B, a decrease of 0.85% year-over-year from $4.02B in FY2025.

TTM revenue
$4.03B
4-quarter sum · USD
YoY growth
-0.85%
vs FY2025 $4.02B
Price / sales
2.23×
mktCap ÷ TTM rev
Revenue per day
$11M
Est. TTM ÷ 365
Revenue / employee
$215K
18700 employees
FY2025
$4.02B
FY2024
$4.05B
5Y CAGR
+2.6%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Charles River Laboratories International, Inc. SEC filings · GAAPUpdated: 2026-06-08

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-27$4.02B-$0.03B-0.85%
2024-12-28$4.05B-$0.08B-1.92%
2023-12-31$4.13B+$0.15B+3.86%
2022-12-31$3.98B+$0.44B+12.31%
2021-12-31$3.54B+$0.62B+21.08%
2020-12-31$2.92B+$0.30B+11.55%
2019-12-31$2.62B+$0.36B+15.67%
2018-12-31$2.27B+$0.41B+21.99%
2017-12-31$1.86B+$0.18B+10.48%
2016-12-31$1.68B+$0.32B+23.34%
CRL revenue by year · CRL revenue history · CRL annual revenue data

Compare revenue vs peers

Medical - Diagnostics & Research

Compare CRL revenue against listed peers. Click any row to open that company's revenue tab.

Revenue breakdown

Segment & Geography
By business segment
Total$4.02B
$2.40B59.8%
$0.85B21.1%
$0.77B19.1%
By geography
Total$3.95B
$2.14B54.2%
$1.10B27.9%
$0.50B12.7%
$0.21B5.2%
Data from Charles River Laboratories International, Inc. annual 10-K filing · FY ending 2025-12-27
CRL revenue breakdown · CRL revenue by segment · CRL revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Charles River Laboratories International, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Charles River Laboratories International, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Charles River Laboratories International, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

CRL revenue · 4 questions

CRL's trailing twelve-month (TTM) revenue is $4.03B. That is a decrease of 0.85% year-over-year from $4.02B in FY2025.

CRL revenueCRL annual revenuewhat is CRL revenueCRL TTM revenue

Source: FMP · Charles River Laboratories International, Inc. SEC filings · GAAP · Charles River Laboratories International, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026